Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

OBJECTIVE: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatme...

Full description

Saved in:
Bibliographic Details
Published in:Anatol J Cardiol
Main Authors: Çavuşoğlu, Yüksel, Korkmaz, Şule, Demirtaş, Selda, Gencer, Erkan, Şaşmaz, Hatice, Mutlu, Fezan, Güneş, Hakan, Mert, Uğur Kadir, Özdemir, Sedat, Kalaycı, Süleyman, Yılmaz, Mehmet Birhan
Format: Artigo
Language:Inglês
Published: Kare Publishing 2016
Subjects:
Original Investigation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5336859/
https://ncbi.nlm.nih.gov/pubmed/26301344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/akd.2015.6156
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items